A A +A
[wpml_language_selector_widget]

SELAMAT DATANG KE PORTAL RASMI
MYHEALTH KEMENTERIAN KESIHATAN MALAYSIA

  1. Home
  2. /
  3. MEDICATION & YOU
  4. /
  5. Medicine Control
  6. /
  7. The role of Medicine...

The role of Medicine Advertisements Board

What is the Medicine Advertisements Board (MAB)?

Have you seen a Kementerian Kesihatan Lembaga Iklan Ubat (KKLIU) approval number which has a 4-digit numbers followed by the year it was approved as follows “KKLIU 0123/2015”? KKLIU numbers will be displayed in the advertisement of medical products or healthcare facilities and services published either in print or electronic media. By the way, do you know who is the authority responsible for approving this KKLIU?

Example of an approved advertisement:

Members of the Medicine Advertisements Board

The authority responsible for approving medical products advertising as well as the advertising of healthcare facilities and services is the Medicine Advertisements Board (MAB). The Board was established under the provisions of the Medicine Advertisements Board Regulations 1976. Establishment and composition of the MAB members are as below:

  1. The Director-General of Health, Ministry of Health Malaysia who shall be an ex-officio member
  2. The Director of Pharmaceutical Services, Ministry of Health Malaysia who shall be an ex-officio member
  3. The Director of Medical Services, Ministry of Health Malaysia who shall be an ex-officio member
  4. The Secretary, Malaysian Medical Association who shall be an ex-officio member
  5. The Secretary, Association of Private Hospitals of Malaysia who shall be an ex-officio member
  6. The Secretary, Federation of Private Medical Practitioners Association who shall be an ex-officio member
  7. One physician in the public service to be appointed by the Minister
  8. One pharmacologist to be appointed by the Minister
  9. One pharmacist in the public service to be appointed by the Minister
  10. One officer from the Ministry of Information nominated by the Minister of Information to be appointed by the Minister

Roles and Responsibilities of the Medicine Advertisements Board

The Board was established in order to discuss the approval for application pertaining to medical products or healthcare facilities and services advertisement received and at its discretion, the Board may:

  • Approve or reject the advertisement application for MAB’s approval
  • Review and revise the MAB policies and advertising guidelines when necessary
  • Cancel or withdrawal of approved advertisements

Client’s Charter

Each application for MAB’s approval submitted by advertisers will be reviewed and evaluated by the Secretariat of MAB. The issuance of approval by the MAB is within 5 working days upon receiving complete application and provided that the advertisement format complies with the MAB guidelines and policies or within 5 working days after the MAB meeting. The application form for MAB’s approval as well as the MAB advertising guidelines and policies are all available on the Pharmaceutical Services Division website: www.pharmacy.gov.my

What If The Applicant Is Not Satisfied With the MAB’s Decision?

Pursuant to Section 6 of the Medicine Advertisements Board Regulations 1976: Any person aggrieved by any decision of the Board may appeal to the Minister of Health whose decision shall be final. All the appeal notice must be made within 14 days from the date of the decision by the MAB. A 30-day period is given for submission of additional data or information or any document for the purposes of the appeal. An appeal will not be entertained if all the required information is not submitted within the time frame stipulated.

Statistic

Statistics of advertisement applications for 2014 are as shown in Table A. Advertisement approvals for year 2012-2014 are shown in Table B.

TABLE A: Advertisement Applications for 2014

TABLE B: Advertisement Approvals for Years 2012 – 2014

Description/Year
2012
2013
2014
Total number of applications 2133 2562 2735
Total number of applications processed within client charter period 2078 2317 2594
Total number of applications processed outside of client charter period 55 245 141
Percentage of applications approvals within client charter period (Target > 90%) 97.4% 90.4% 94.8%

References

  1. Website www.pharmacy.gov.my
  2. Medicine Advertisements Board Regulations 1976
Last Reviewed : 05 June 2015
Writer/Translator : Wong Hui Shean
Accreditor : Umikalsom bt. Ibrahim

 

Artikel Berkaitan

Gelenggang Leaves (Cassia Senna)

Gelenggang leaves or Senna leaves are herbaceous shrubs with an average height of 1 to 1.5 metres. Cassia senna leaves (C. acutifolia Delile) and Cassia angustifolia Vahl are the scientific names for gelenggang leaves.

Antihistamine

Introduction Antihistamine is a medicine used to treat allergy. It

ALAMAT

Bahagian Pendidikan Kesihatan,
Kementerian Kesihatan Malaysia,
Aras 1-3, Blok E10, Kompleks E,
Kompleks Pentadbiran Kerajaan Persekutuan,
62590 Putrajaya, Malaysia.

TALIAN AM :   +603 8000 8000

FAKS :   +603 8888 6200

EMEL :   myhealth@moh.gov.my

BILANGAN PENGUNJUNG : 227,767,430

TARIKH AKHIR KEMASINI :
2024-07-16 15:32:21

PAPARAN TERBAIK   Paparan terbaik menggunakan pelayar Google Chrome Version 57.0, Mozilla Firefox Version 52.0 dengan resolusi 1366 x 768px

Hakcipta Terpelihara ©2005-2022 Bahagian Pendidikan Kesihatan, Kementerian Kesihatan Malaysia